scholarly journals Cell viability and hydration assay based on metamaterial-enhanced terahertz spectroscopy

RSC Advances ◽  
2017 ◽  
Vol 7 (85) ◽  
pp. 53963-53969 ◽  
Author(s):  
Yu Liu ◽  
Mingjie Tang ◽  
Liangping Xia ◽  
Wenjing Yu ◽  
Jia Peng ◽  
...  

We analyze cell viability and hydration state of tumor cells in a label-free manner based on metamaterial-enhanced terahertz spectroscopy.

ACS Omega ◽  
2018 ◽  
Vol 3 (4) ◽  
pp. 3882-3891 ◽  
Author(s):  
Beatrix Peter ◽  
Rita Ungai-Salanki ◽  
Bálint Szabó ◽  
Agoston G. Nagy ◽  
Inna Szekacs ◽  
...  

Author(s):  
Amber M. Tavener ◽  
Megan C. Phelps ◽  
Richard L. Daniels

AbstractGlioblastoma (GBM) is a lethal astrocyte-derived tumor that is currently treated with a multi-modal approach of surgical resection, radiotherapy, and temozolomide-based chemotherapy. Alternatives to current therapies are urgently needed as its prognosis remains poor. Anthracyclines are a class of compounds that show great potential as GBM chemotherapeutic agents and are widely used to treat solid tumors outside the central nervous system. Here we investigate the cytotoxic effects of doxorubicin and other anthracyclines on GL261 glioma tumor cells in anticipation of novel anthracycline-based CNS therapies. Three methods were used to quantify dose-dependent effects of anthracyclines on adherent GL261 tumor cells, a murine cell-based model of GBM. MTT assays quantified anthracycline effects on cell viability, comet assays examined doxorubicin genotoxicity, and flow cytometry with Annexin V/PI staining characterized doxorubicin-induced apoptosis and necrosis. Dose-dependent reductions in GL261 cell viability were found in cells treated with doxorubicin (EC50 = 4.9 μM), epirubicin (EC50 = 5.9 μM), and idarubicin (EC50 = 4.4 μM). Comet assays showed DNA damage following doxorubicin treatments, peaking at concentrations of 1.0 μM and declining after 25 μM. Lastly, flow cytometric analysis of doxorubicin-treated cells showed dose-dependent induction of apoptosis (EC50 = 5.2 μM). Together, these results characterized the cytotoxic effects of anthracyclines on GL261 glioma cells. We found dose-dependent apoptotic induction; however at high concentrations we find that cell death is likely necrotic. Our results support the continued exploration of anthracyclines as compounds with significant potential for improved GBM treatments.


2017 ◽  
Vol 8 (2) ◽  
pp. 536 ◽  
Author(s):  
Dhananjay Kumar Singh ◽  
Caroline C. Ahrens ◽  
Wei Li ◽  
Siva A. Vanapalli

2016 ◽  
Vol 27 ◽  
pp. ix15-ix16
Author(s):  
Y.F. Lee ◽  
N. Ramalingam ◽  
L. Szpankowski ◽  
A. Leyrat ◽  
N.D. Angeles ◽  
...  

2021 ◽  
Author(s):  
Ya-jing Zhang ◽  
Zhen-lin Mu ◽  
Ping Deng ◽  
Yi-dan Liang ◽  
Li-chuan Wu ◽  
...  

Abstract Cancer is one of the leading causes of death in the world. It is very important to find drugs with high efficiency, low toxicity, and low side effects for the treatment of cancer. Flavonoids and their derivatives with broad biological functions have been recognized as anti-tumor chemicals. 8-Formylophiopogonanone B (8-FOB), a naturally existed homoisoflavonoids with rarely known biological functions, needs pharmacological evaluation. In order to explore the possible anti-tumor action of 8-FOB, we used six types of tumor cells to evaluate in vitro effects of this agent on cell viability and tested the effects on clone formation ability, scratching wound-healing, and apoptosis. In an attempt to elucidate the mechanism of pharmacological action, we examined 8-FOB-induced intracellular oxidative stress and -disrupted mitochondrial function. Results suggested that 8-FOB could suppress tumor cell viability, inhibit cell migration and invasion, induce apoptosis, and elicit intracellular ROS production. Among these six types of tumor cells, the nasopharyngeal carcinoma CNE-1 cells were the most sensitive cancer cells to 8-FOB treatment. Intracellular ROS production played a pivotal role in the anti-tumor action of 8-FOB. Our present study is the first to document that 8-FOB has anti-tumor activity in vitro and increases intracellular ROS production, which might be responsible for its anti-tumor action. The anti-tumor pharmacological effect of 8-FOB is worthy of further investigation.


2020 ◽  
Author(s):  
Chenfei Hu ◽  
Shenghua He ◽  
Young Jae Lee ◽  
Yuchen He ◽  
Edward M. Kong ◽  
...  

AbstractExisting approaches to evaluate cell viability involve cell staining with chemical reagents. However, this step of exogenous staining makes these methods undesirable for rapid, nondestructive and long term investigation. Here, we present instantaneous viability assessment of unlabeled cells using phase imaging with computation specificity (PICS). This new concept utilizes deep learning techniques to compute viability markers associated with the specimen measured by quantitative phase imaging. Demonstrated on HeLa cells culture, the proposed method reports approximately 95% accuracy in identifying injured and dead cells. Further comparison of cell morphology with labeled HeLa cells suggests that potential adverse effect on cell dynamics introduced by the viability reagents can be avoided using the label-free investigation method, which would be valuable for a broad range of biomedical applications.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Manjima Dhar ◽  
Edward Pao ◽  
Corinne Renier ◽  
Derek E. Go ◽  
James Che ◽  
...  

2015 ◽  
Vol 87 (8) ◽  
pp. 741-749 ◽  
Author(s):  
Eric M. Strohm ◽  
Michael C. Kolios
Keyword(s):  

2018 ◽  
Vol 30 (13) ◽  
pp. 4372-4382 ◽  
Author(s):  
Liwei Yang ◽  
He Sun ◽  
Wenning Jiang ◽  
Ting Xu ◽  
Bing Song ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document